Skip to main content

The 9p21 polymorphism is linked with atrial fibrillation during acute phase of ST-segment elevation myocardial infarction

Abstract

The aim of the study was to find whether patients carrying polymorphic allele of the rs10757278 polymorphism from 9p21 locus have changed risk of arrhythmia (atrial fibrillation, AF; sustained ventricular tachycardia or ventricular fibrillation, sVT/VF) during acute phase of myocardial infarction. Retrospective analysis of data collected prospectively from two independent centers was performed. The clinical data were pooled from two independent cardiac registries: (1) the Warsaw ACS genetic registry (STEMI and NSTEMI/UA patients hospitalized in the years 2008–2011; only STEMI patients were analyzed); (2) the Bialystok STEMI genetic registry (STEMI patients hospitalized in years 2001–2005, who survived the first 48 h from hospital admission). Data regarding sVT/VF and AF within first 24 h were analyzed. The patients were genotyped with rs10757278 polymorphism. 1083 patients were included in the analysis; 62 (5.7 %) patients had sVT/VF during acute phase and 78 (7.2 %) patients had AF, 46 (4.2 %) patients had new-onset AF. Minor allele frequency in all patients with AF was significantly different from those without AF (0.40 vs 0.51, p = 0.0096). When only new-onset AF was analyzed, the trend was the same, with significant protective effect in recessive model [OR 0.41 (95 % CI 0.17–0.97), p = 0.025]. The effect was independent of age and GRACE score. No relationship was found between sVT/VF and rs10757278. Patients with STEMI, who survived until hospitalization with polymorphic allele of 9p21 rs10757278 SNP have less AF during acute phase of STEMI. SNP rs10757278 is not linked with sVT/VF in acute phase of STEMI.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE, Barrett JH, König IR, Stevens SE, Szymczak S, Tregouet DA, Iles MM, Pahlke F, Pollard H, Lieb W, Cambien F, Fischer M, Ouwehand W, Blankenberg S, Balmforth AJ, Baessler A, Ball SG, Strom TM, Braenne I, Gieger C, Deloukas P, Tobin MD, Ziegler A, Thompson JR, Schunkert H, WTCCC and the Cardiogenics Consortium (2007) Genome-wide association analysis of coronary artery disease. N Engl J Med 357:443–453

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, Jonasdottir A, Sigurdsson A, Baker A, Palsson A, Masson G, Gudbjartsson DF, Magnusson KP, Andersen K, Levey AI, Backman VM, Matthiasdottir S, Jonsdottir T, Palsson S, Einarsdottir H, Gunnarsdottir S, Gylfason A, Vaccarino V, Hooper WC, Reilly MP, Granger CB, Austin H, Rader DJ, Shah SH, Quyyumi AA, Gulcher JR, Thorgeirsson G, Thorsteinsdottir U, Kong A, Stefansson K (2007) A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316:1491–1493

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Buysschaert I, Carruthers KF, Dunbar DR, Peuteman G, Rietzschel E, Belmans A, Hedley A, De Meyer T, Budaj A, Van de Werf F, Lambrechts D, Fox KA (2010) A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE Genetics Study. Eur Heart J 31:1132–1141

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Horne BD, Carlquist JF, Muhlestein JB, Bair TL, Anderson JL (2008) Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery disease. Circ Cardiovasc Genet 1:85–92

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Szpakowicz A, Kiliszek M, Pepinski W, Waszkiewicz E, Franaszczyk M, Skawronska M, Ploski R, Niemcunowicz-Janica A, Dobrzycki S, Opolski G, Musial WJ, Kaminski KA (2014) Polymorphism of 9p21.3 locus is associated with 5-year survival in high-risk patients with myocardial infarction. PLoS One 9(8):e104635

    Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Demirel F, Rasoul S, Elvan A, Ottervanger JP, Dambrink JH, Gosselink AM, Hoorntje JC, Ramdat Misier AR, van ‘t Hof AW (2015) Impact of out-of-hospital cardiac arrest due to ventricular fibrillation in patients with ST-elevation myocardial infarction admitted for primary percutaneous coronary intervention: impact of ventricular fibrillation in STEMI patients. Eur Heart J Acute Cardiovasc Care 4:16–23

    Article  PubMed  Google Scholar 

  7. 7.

    Consuegra-Sánchez L, Melgarejo-Moreno A, Galcerá-Tomás J, Alonso-Fernández N, Díaz-Pastor Á, Escudero-García G, Jaulent-Huertas L, Vicente-Gilabert M (2015) Short- and long-term prognosis of previous and new-onset atrial fibrillation in ST-segment elevation acute myocardial infarction. Rev Esp Cardiol (Engl Ed) 68:31–38

    Article  Google Scholar 

  8. 8.

    Anzai A, Maekawa Y, Kodaira M, Mogi S, Arai T, Kawakami T, Kanazawa H, Hayashida K, Yuasa S, Kawamura A, Fukuda K (2015) Prognostic implications of optimal medical therapy in patients undergoing percutaneous coronary intervention for acute coronary syndrome in octogenarians. Heart Vessels 30:186–192

    Article  PubMed  Google Scholar 

  9. 9.

    Newton-Cheh C, Cook NR, VanDenburgh M, Rimm EB, Ridker PM, Albert CM (2009) A common variant at 9p21 is associated with sudden and arrhythmic cardiac death. Circulation 120:2062–2068

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Wahlstrand B, Orho-Melander M, Delling L, Kjeldsen S, Narkiewicz K, Almgren P, Hedner T, Melander O (2009) The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension. J Hypertens 27:769–773

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Szpakowicz A, Kiliszek M, Pepiński W, Waszkiewicz E, Franaszczyk M, Skawrońska M, Dobrzycki S, Niemcunowicz-Janica A, Ploski R, Opolski G, Musiał WJ, Kamiński KA (2015) The rs9982601 polymorphism of the region between the SLC5A3/MRPS6 and KCNE2 genes associated with a prevalence of myocardial infarction and subsequent long-term mortality. Pol Arch Med Wewn 125(4):240–248

    PubMed  Google Scholar 

  12. 12.

    Szpakowicz A, Pepinski W, Waszkiewicz E, Maciorkowska D, Skawronska M, Niemcunowicz-Janica A, Dobrzycki S, Musial WJ, Kaminski KA (2014) The influence of renal function on the association of rs854560 polymorphism of paraoxonase 1 gene with long-term prognosis in patients after myocardial infarction. Heart Vessels. doi:10.1007/s00380-014-0574-8

    PubMed  PubMed Central  Google Scholar 

  13. 13.

    Julian DG, Boissel JP, DeBono DP, Fox KAA, Heikkila J, LopezBescos L Neuhaus KL, Schroder R, Sleight P, Specchia G, Sigurdssonand A, Swedberg K, Turina M, Genoni M, Verheugt FWA, van de Werf F, Zijlstra F (1996) The task force on the management of acute myocardial infarction of the European Society of Cardiology. Acute myocardial infarction: pre-hospital and in-hospital management. Eur Heart J 17(1):43–63

  14. 14.

    Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, Julian D, Lengyel M, Neumann FJ, Ruzyllo W, Thygesen C, Underwood SR, Vahanian A, Verheugt FW, Wijns W (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24:28–66

    PubMed  Google Scholar 

  15. 15.

    Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, ESC Committee for Practice Guidelines (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the european society of cardiology. Eur Heart J 29:2909–2945

    Article  PubMed  Google Scholar 

  16. 16.

    Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA, Global Registry of Acute Coronary Events Investigators (2003) Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163:2345–2353

    Article  PubMed  Google Scholar 

  17. 17.

    Ni X, Zhang J (2014) Association between 9p21 genomic markers and ischemic stroke risk: evidence based on 21 studies. PLoS One 9(3):e90255

    Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Congrains A, Kamide K, Oguro R, Yasuda O, Miyata K, Yamamoto E, Kawai T, Kusunoki H, Yamamoto H, Takeya Y, Yamamoto K, Onishi M, Sugimoto K, Katsuya T, Awata N, Ikebe K, Gondo Y, Oike Y, Ohishi M, Rakugi H (2012) Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis 220:449–455

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Lahtinen AM, Noseworthy PA, Havulinna AS, Jula A, Karhunen PJ, Kettunen J, Perola M, Kontula K, Newton-Cheh C, Salomaa V (2012) Common genetic variants associated with sudden cardiac death: the FinSCDgen study. PLoS One 7(7):e41675. doi:10.1371/journal.pone.0041675

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was supported by National Science Center, Poland (N N 402 529139). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Marek Kiliszek.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 13 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kiliszek, M., Szpakowicz, A., Franaszczyk, M. et al. The 9p21 polymorphism is linked with atrial fibrillation during acute phase of ST-segment elevation myocardial infarction. Heart Vessels 31, 1590–1594 (2016). https://doi.org/10.1007/s00380-015-0774-x

Download citation

Keywords

  • 9p21 polymorphism
  • SNP
  • STEMI
  • Myocardial infarction
  • Atrial fibrillation
  • Ventricular arrhythmia